Metabolic benefits of switching to tenofovir/lamivudine after long-term use of stavudine/lamivudine in NNRTI-based antiretroviral regimens: a prospective study.

Source:http://linkedlifedata.com/resource/pubmed/id/21382413

Download in:

View as

General Info

PMID
21382413